Monitor subsequent filings for total utilization of the $50 million facility and any updates on the company's cash runway, especially given the conflict-of-interest disclosure regarding the lender being an affiliate of the largest stockholder.
Price Chart
Executive Summary
TuHURA Biosciences drew down an additional $650,000 from its existing $50 million revolving credit facility with Parkview Holdings One LLC on September 14, 2026. The funds are earmarked for general corporate purposes. This is a routine draw on a previously established facility and does not signal a material change in the company's financial condition.
Key Facts
- Borrowed $650,000 under a $50 million revolving credit facility on September 14, 2026.
- Facility matures on April 21, 2031.
- Proceeds to be used for general corporate purposes.
- Lender is Parkview Holdings One LLC, an affiliate of the company's largest stockholder.
Financial Impact
Additional draw of $650,000 on a $50 million revolving credit facility; total drawn amount not disclosed.
Risk Factors
- Potential conflict of interest as lender is an affiliate of the company's largest stockholder.
- Continued reliance on debt financing may indicate insufficient operating cash flow.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-394473 |
| Document: 0001193125-26-394473-index-headers.html | 0001193125-26-394473 |
| Document: 0001193125-26-394473-index.html | 0001193125-26-394473 |
| Document: 0001193125-26-394473.txt | 0001193125-26-394473 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.03 (+14.04%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.03 (−2.87%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.03 (−4.25%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.03 (−8.56%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.03 (−6.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers